This is the first description of M1's anti-melanoma properties.
We demonstrate a mechanism of action by multi-parameter analyses.
We show therapeutic potential of AT1R inhibition on myeloid-derived suppressor cells as a novel therapeutic target.
We offer new insights into the importance of blocking initial pathways of tumor metastases.